mk 0852 has been researched along with eptifibatide in 2 studies
Studies (mk 0852) | Trials (mk 0852) | Recent Studies (post-2010) (mk 0852) | Studies (eptifibatide) | Trials (eptifibatide) | Recent Studies (post-2010) (eptifibatide) |
---|---|---|---|---|---|
17 | 2 | 0 | 907 | 220 | 212 |
Protein | Taxonomy | mk 0852 (IC50) | eptifibatide (IC50) |
---|---|---|---|
Integrin beta-3 | Homo sapiens (human) | 0.226 | |
Integrin alpha-IIb | Homo sapiens (human) | 0.226 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Heptinstall, S; Storey, RF; Wilcox, RG | 1 |
Lages, B; Weiss, HJ | 1 |
1 trial(s) available for mk 0852 and eptifibatide
Article | Year |
---|---|
Differential effects of glycoprotein IIb/IIIa antagonists on platelet microaggregate and macroaggregate formation and effect of anticoagulant on antagonist potency. Implications for assay methodology and comparison of different antagonists.
Topics: Adenosine Diphosphate; Anticoagulants; Citrates; Collagen; Eptifibatide; Hirudins; Humans; Nephelometry and Turbidimetry; Oligopeptides; Peptides; Peptides, Cyclic; Piperazines; Piperidines; Platelet Aggregation Inhibitors; Platelet Count; Platelet Glycoprotein GPIIb-IIIa Complex; Sodium Citrate; Thiazolidines | 1998 |
1 other study(ies) available for mk 0852 and eptifibatide
Article | Year |
---|---|
Greater inhibition of platelet procoagulant activity by antibody-derived glycoprotein IIb--IIIa inhibitors than by peptide and peptidomimetic inhibitors.
Topics: Abciximab; Antibodies, Monoclonal; Blood Platelets; Calcium; Cytosol; Enzyme Inhibitors; Eptifibatide; Fura-2; Humans; Immunoglobulin Fab Fragments; Immunoglobulin Fragments; Oligopeptides; Peptides; Peptides, Cyclic; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thiazolidines; Thromboplastin | 2001 |